As the flu season approaches from the Southern Hemisphere this year, plenty of U.S. FDA-approved influenza vaccines are available to protect people.
However, anyone can get the flu before they are vaccinated, and occasionally even after.
To help reduce the severity of influenza in children, the FDA recently extended the use of a leading oral antiviral medicine.
Influenza Antiviral Works Before and After Annual Flu Shots
Monkeypox Variants Gain New Names
The World Health Organization (WHO) announced today a group of global experts has agreed on new names for monkeypox virus variants using Roman numerals.
These classifications are part of ongoing efforts to align the names of the monkeypox disease, virus, and variants—or clades—with current best practices.
COVID-19 Vaccination Rates Lower Among Adults With Vision, Hearing Disability
Compared with those with little to no impairment, adults with serious disability less likely to initiate COVID-19 vaccination
COVID-19 mRNA Vaccines Are Safe in Pregnancy
Compared with nonpregnant vaccinated women, pregnant vaccinated women had lower odds of a significant health event after vaccination
Symptoms Linger for Some Children After Acute COVID-19, MIS-C
Persistent symptoms or activity impairment seen in more than 25 percent of children hospitalized with COVID-19, MIS-C
Three At-Home COVID-19 Tests Needed to Confirm Negative Result, FDA Says
Agency said the latest research suggests that taking just two antigen tests misses too many infections
Polio Risk Returns to London and Lower New York
The poliovirus has been surprisingly confirmed in non-endemic communities over the past month, thanks to innovative wastewater surveillance systems. The advantage of wastewater sampling is that it captures the waste contributions of society without divulging individual identities.
A total of 116 PV2 isolates have been identified in 19 sewage samples collected in London, England, between February and July 5, 2022. Most are vaccine-like viruses; only a few have sufficient mutations to be classified as vaccine-derived poliovirus (VDPV2).
Survival Benefit With Triple Therapy for Severe COVID-19
Compared with dual therapy, significant survival benefit seen with dexamethasone, remdesivir, and baricitinib but no change in length of stay
CDC Eases COVID-19 Social Distancing Guidance
Agency suggests Americans consider what settings are riskier based on crowds, poor ventilation, and personal risks
Survival Benefit Seen With Triple Therapy for Severe COVID-19
Compared with dual therapy, significant survival benefit seen with dexamethasone, remdesivir, and baricitinib but no change in length of stay